IDXG · Categories · Form 4
IDXG - SEC Form 4 insider transactions
Interpace Biosciences, Inc. (IDXG) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for IDXG
- Large owner 1315 Capital Ii, L.P. converted options into 9,405,941 shares (SEC Form 4)4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- Large owner Ampersand 2018 Limited Partnership converted options into 13,861,386 shares (SEC Form 4)4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- Chief Financial Officer Mccarthy Christopher converted options into 38,475 shares, increasing direct ownership by 463% to 46,791 units (SEC Form 4)4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- SEC Form 4 filed by Large owner 1315 Capital Ii, L.P.4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- SEC Form 4 filed by Large owner Ampersand 2018 Limited Partnership4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- Mccarthy Christopher was granted 10,000 shares, increasing direct ownership by 28% to 45,644 units (SEC Form 4)4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- SEC Form 4: Mccarthy Christopher was granted 25,000 shares, increasing direct ownership by 235% to 35,644 units4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- SEC Form 4 filed by Aggarwal Vijay4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- SEC Form 4 filed by Interpace Biosciences, Inc.4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- SEC Form 4: John Thomas Freeburg was granted 50,000 units of Common Stock, increasing direct ownership by 2,500% to 52,000 units4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- SEC Form 4: Peter Kamin bought $260,104 worth of Common Stock (83,250 units at $3.12), increasing ownership by 13% to 270,108 units4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)
- SEC Form 4: J. Robert Gorman was granted 12,438 units of Common Stock, increasing ownership by 197% to 18,759 units4 - INTERPACE BIOSCIENCES, INC. (0001054102) (Issuer)